INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 21 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $98,000 | +326.1% | 100,000 | +300.0% | 0.00% | – |
| Q1 2022 | $23,000 | -87.6% | 25,000 | -87.2% | 0.00% | – |
| Q4 2021 | $185,000 | +18400.0% | 196,000 | +19500.0% | 0.00% | – |
| Q3 2019 | $1,000 | -99.4% | 1,000 | -99.5% | 0.00% | – |
| Q2 2019 | $166,000 | -83.2% | 187,000 | -81.4% | 0.00% | – |
| Q1 2019 | $991,000 | +7.0% | 1,005,000 | 0.0% | 0.00% | – |
| Q4 2018 | $926,000 | -8.9% | 1,005,000 | 0.0% | 0.00% | – |
| Q3 2018 | $1,016,000 | +21.8% | 1,005,000 | 0.0% | 0.00% | – |
| Q2 2018 | $834,000 | +3.6% | 1,005,000 | 0.0% | 0.00% | – |
| Q1 2018 | $805,000 | +16000.0% | 1,005,000 | +16650.0% | 0.00% | – |
| Q4 2017 | $5,000 | -99.9% | 6,000 | -99.9% | 0.00% | -100.0% |
| Q3 2017 | $5,177,000 | -33.9% | 6,701,000 | -16.8% | 0.00% | -50.0% |
| Q2 2017 | $7,835,000 | -11.3% | 8,056,000 | -15.0% | 0.00% | -20.0% |
| Q1 2017 | $8,831,000 | -32.5% | 9,476,000 | -35.4% | 0.01% | -28.6% |
| Q4 2016 | $13,080,000 | +59.1% | 14,676,000 | +99.6% | 0.01% | +40.0% |
| Q3 2016 | $8,219,000 | – | 7,351,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|